Project Details
Description
To prospectively determine, in ALS patients who are prescribed nocturnal NIV as per current practice parameters, whether PSG titrated and adjusted NIV (P-NIV) is associated with improved preservation of diurnal respiratory function and quality of life over the course of the first 6 months after prescription of NIV, compared with standard of practice prescription and adjustment of NIV (S-NIV). Ancillary aims are to determine to what extent the prescription for P-NIV differs from S-NIV; whether respiratory function is improved in the morning following a night of P-NIV compared with S-NIV; to what extent S-NIV is associated with failure of nocturnal oxygenation and/or ventilation; and if P-NIV use is associated with improved survival, compared with S-NIV use.
Status | Not started |
---|
ASJC Scopus Subject Areas
- Clinical Neurology
- Pulmonary and Respiratory Medicine
- Neurology
- Medicine(all)